Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qigu Capsule is a Traditional Chinese Medicine (TCM) hospital preparation developed by Shuguang Hospital, which is affiliated with the Shanghai University of Traditional Chinese Medicine. The formulation is based on the TCM therapeutic principle of "Focus on Both Tendons and Bones" (筋骨并重), which emphasizes the integrated treatment of the skeletal and muscular systems. It is primarily investigated for its potential to treat age-related musculoskeletal conditions, including osteoporosis, dysmobility syndrome, and various muscle diseases such as sarcopenia. In clinical research settings, it has been used to evaluate the Body-Mass-Frequency-Index (BMFI), a metric designed to reflect the physical health status and musculoskeletal integrity of elderly populations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qigu Capsule.